Berry Genomics And BioNano Genomics Partner for Next-Gen Genome Mapping

Berry Genomics of Beijing and San Diego's BioNano Genomics agreed to co-develop a next-generation mapping (NGM) system that will provide cost-effective, easy-to-use assays for detection of chromosomal structural variations in China. The assays will be built on BioNano's Irys® instrument, an NGM platform. The new assays and instrument system will be validated in China clinical settings and submitted to the CFDA for registration review as a medical device. More details.... Share this with colleagues: // //